Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)

Clinical trial NCT00619359 · COMPLETED

Trial details

NCT number: NCT00619359
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting (CINV)

Start date: 2008-02-01
Primary completion: 2009-06-01
Enrollment: 2322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.